BioSniper
ZH
Toggle language
Open menu
PDUFA Date
PDUFA Date: lorundrostat
December 22, 2026
Company
Mineralys Therapeutics, Inc. (MLYS)
Drug
lorundrostat
Indication
adult patients with hypertension in combination with other antihypertensive drugs had been accepted
Other upcoming events for MLYS
Phase 3 Readout
Phase 3 Topline: An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundro
Dec 1, 2026
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
MLYS Overview
PDUFA Dates
Phase 3 Readouts